and packaging of the investigational drug, whether provided by a sponsor in its final form or compounded by the pharmacy. The Investigational Drug Service (IDS) at the University of Michigan ...
Principal Investigators on treatment protocols that involve an Investigational New Drug (IND) must complete Form FDA 1572, which the sponsor then submits to FDA. Form FDA 1572 is the contract between ...
By Joachim Leube, Bayer HealthCare Manufacturing, Italy New options of therapy are needed for a considerable number of diseases.
The last decade has seen a “dramatic increase” in investigational new drug (IND) applications for cannabis-derived products, according to the U.S. Food and Drug Administration. In a paper ...
An Investigational New Drug (IND) is a drug or biological drug that has not been approved for general use by the FDA. It is used in a clinical trial to investigate its safety and efficacy. The term ...